BIOLASE (BIOL) Releases Quarterly Earnings Results, Hits Expectations

BIOLASE (NASDAQ:BIOL) released its quarterly earnings results on Wednesday. The medical technology company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04), Bloomberg Earnings reports. BIOLASE had a negative net margin of 36.28% and a negative return on equity of 74.51%.

Shares of BIOLASE (NASDAQ BIOL) opened at $0.46 on Thursday. BIOLASE has a 1 year low of $0.28 and a 1 year high of $1.45.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at

BIOLASE Company Profile

BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.

Earnings History for BIOLASE (NASDAQ:BIOL)

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with's FREE daily email newsletter.

Leave a Reply